Study of Apatinib and Capecitabine Combination to Maintain Treating Metastatic Colorectal Cancer
Clinical trial NCT03132025 · UNKNOWN
Trial details
- NCT number
- NCT03132025
- Sponsor
- Yanqiao Zhang
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-30
- Primary completion
- 2018-02-28
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.